Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Curcuma longa L. may help reduce prostate inflammation.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Testosterone reduces, while finasteride enhances, morphine's pain relief.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Compound 4 is a promising treatment for hair loss with low toxicity.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

TRPV3 is important for skin health and could be a target for treating skin diseases.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.